((lp0
VisWord
p1
aVcase
p2
aVstops
p3
aVstem
p4
accopy_reg
_reconstructor
p5
(cnltk.probability
FreqDist
p6
c__builtin__
dict
p7
(dp8
S'primary tool'
p9
I1
sS'candidate molecul'
p10
I1
sS'all'
p11
I1
sS'represent'
p12
I1
sS'datum'
p13
I2
sS'reclust'
p14
I1
sS'cutoff'
p15
I2
sS'cancer studi'
p16
I2
sS'tolerance induct'
p17
I1
sS'survival predictions for individual pati'
p18
I1
sS'oci'
p19
I1
sS'morpholog'
p20
I1
sS'nois'
p21
I1
sS'of neural network'
p22
I1
sS'activ'
p23
I1
sS'program'
p24
I1
sS'sens'
p25
I1
sS'cell-like tumor'
p26
I2
sS'analys'
p27
I1
sS'gene panel network'
p28
I1
sS'individual pati'
p29
I2
sS'relative impact'
p30
I1
sS'predict'
p31
I2
sS'risk'
p32
I6
sS'viewpoint'
p33
I1
sS'target antigen'
p34
I2
sS'non-survivor'
p35
I4
sS'express'
p36
I5
sS'expression panel'
p37
I1
sS'preparation for'
p38
I1
sS'efficacious approaches for limiting tumor growth'
p39
I1
sS'candid'
p40
I1
sS'large b-cell lymphoma'
p41
I1
sS'middle-layer neuron'
p42
I5
sS'biopsi'
p43
I1
sS'induct'
p44
I1
sS'oci ly1'
p45
I1
sS'experi'
p46
I1
sS'organ'
p47
I1
sS'informative gen'
p48
I1
sS'list'
p49
I1
sS'iter'
p50
I1
sS'correl'
p51
I1
sS'negative donor'
p52
I1
sS'survival prob'
p53
I1
sS'classification accuraci'
p54
I2
sS'round'
p55
I1
sS'middle layer neuron'
p56
I1
sS'respond'
p57
I1
sS'self-organizing-map'
p58
I1
sS'neuralwork'
p59
I1
sS'training sess'
p60
I2
sS'alizadeh studi'
p61
I1
sS'antigen'
p62
I2
sS'investig'
p63
I1
sS'probability plot'
p64
I1
sS'reserv'
p65
I1
sS'disadvantag'
p66
I1
sS'acute lymphoblastic leukemia'
p67
I1
sS'gene express'
p68
I5
sS'index'
p69
I1
sS'error'
p70
I6
sS'optimum outcome classif'
p71
I1
sS'subselect'
p72
I1
sS'gene clust'
p73
I2
sS'individual scor'
p74
I1
sS'cell'
p75
I1
sS'radiation therapi'
p76
I1
sS'survival probability plot'
p77
I1
sS'network softwar'
p78
I1
sS'vector machin'
p79
I2
sS'impact'
p80
I1
sS'non-linear'
p81
I1
sS'propagation network'
p82
I1
sS'coeffici'
p83
I2
sS'diagnostic accuraci'
p84
I4
sS'prognostic index'
p85
I1
sS'sigmoidal transf'
p86
I1
sS'outcome classif'
p87
I1
sS'k-nearest neighbor'
p88
I1
sS'diagnosing lymphoma'
p89
I1
sS'normal training interv'
p90
I1
sS'cox'
p91
I1
sS'som class'
p92
I1
sS'biological analys'
p93
I1
sS'precis'
p94
I1
sS'svm model'
p95
I1
sS'cancer pati'
p96
I1
sS'three-lay'
p97
I1
sS'studi'
p98
I6
sS'gene'
p99
I40
sS'follow-up donor'
p100
I1
sS'chanc'
p101
I1
sS'new network'
p102
I1
sS'final subset'
p103
I1
sS'cancer'
p104
I2
sS'perou'
p105
I1
sS'error cutoff'
p106
I2
sS'subcategori'
p107
I1
sS'kinase receptor gen'
p108
I1
sS'subselection choic'
p109
I1
sS'poll'
p110
I1
sS'signatur'
p111
I2
sS'plot'
p112
I1
sS'score'
p113
I4
sS'dlbcl'
p114
I6
sS'distinct'
p115
I1
sS'semi-quantitative assess'
p116
I1
sS'microarray data chip'
p117
I1
sS'kaplan mei'
p118
I2
sS'gene profil'
p119
I1
sS'panel network'
p120
I2
sS'criteria'
p121
I3
sS'approaches for limiting tumor growth'
p122
I1
sS'basi'
p123
I1
sS'donor profil'
p124
I2
sS'strategi'
p125
I1
sS'naive intuit'
p126
I1
sS'neuron'
p127
I20
sS'disadvantage of'
p128
I1
sS'numerous recent canc'
p129
I1
sS'inlier'
p130
I1
sS'train'
p131
I14
sS'survival predictions for'
p132
I1
sS'neural network strategi'
p133
I1
sS'relative dependence of th'
p134
I1
sS'cluster'
p135
I1
sS'quartil'
p136
I1
sS'prepar'
p137
I1
sS'work'
p138
I2
sS'mh'
p139
I1
sS'rejection antigen'
p140
I1
sS'backpropagation network'
p141
I1
sS'negative scor'
p142
I1
sS'outcom'
p143
I3
sS'non-tumor'
p144
I1
sS'learn'
p145
I1
sS'immunohistochem'
p146
I1
sS'robin'
p147
I1
sS'overtrain'
p148
I2
sS'prognosis accuraci'
p149
I2
sS'vectors for a neural network'
p150
I2
sS'tumor-expressed gen'
p151
I1
sS'chip'
p152
I2
sS'net profil'
p153
I1
sS'retest'
p154
I1
sS'enhanced identification of'
p155
I1
sS'training iter'
p156
I1
sS'neural network'
p157
I17
sS'contribut'
p158
I1
sS'differenti'
p159
I10
sS'survival predict'
p160
I2
sS'round robin'
p161
I2
sS'for differenti'
p162
I1
sS'situ'
p163
I1
sS'microarray'
p164
I2
sS'clinical outcom'
p165
I1
sS'prognosis classification accuraci'
p166
I1
sS'enhanced identification of cell-typ'
p167
I1
sS'tumor-encoded gen'
p168
I1
sS'tumor growth'
p169
I2
sS'artificial network'
p170
I1
sS'donor pool'
p171
I1
sS'leukemia'
p172
I2
sS'prognostic outcom'
p173
I1
sS'survival categori'
p174
I1
sS'round-robin train'
p175
I1
sS'dhanasekaran'
p176
I1
sS'redund'
p177
I2
sS'fl'
p178
I1
sS'unimpair'
p179
I1
sS'metastatic tumor'
p180
I1
sS'germinal center b cell-like tumor'
p181
I1
sS'attempt'
p182
I1
sS'identification of cell-typ'
p183
I1
sS'relative dependence of'
p184
I1
sS'potential target'
p185
I1
sS'model'
p186
I2
sS'acute myeloid leukemia'
p187
I1
sS'follow-up studi'
p188
I2
sS'qualitative network'
p189
I2
sS'all distinct'
p190
I1
sS'therapi'
p191
I1
sS'precise classif'
p192
I1
sS'influential gen'
p193
I1
sS'momentum coeffici'
p194
I1
sS'for a neural network'
p195
I1
sS'tyrosine kinase receptor gen'
p196
I1
sS'predictions for individual pati'
p197
I1
sS'efficacious approach'
p198
I1
sS'vectors for'
p199
I1
sS'identif'
p200
I2
sS'statistical correl'
p201
I1
sS'absolute best poss'
p202
I1
sS'receptor gen'
p203
I1
sS'overview'
p204
I2
sS'signature gen'
p205
I2
sS'gel'
p206
I1
sS'enhanced identif'
p207
I1
sS'momentum'
p208
I1
sS'non-surviv'
p209
I1
sS'prognostic network'
p210
I1
sS'aml'
p211
I3
sS'gene list'
p212
I1
sS'b-cell lymphoma'
p213
I1
sS'linear neural network'
p214
I1
sS'bit'
p215
I2
sS'lymphoma'
p216
I4
sS'backpropagation neural network'
p217
I1
sS'choic'
p218
I1
sS'efficacious approaches for'
p219
I1
sS'radiat'
p220
I1
sS'non-respons'
p221
I1
sS'gene stag'
p222
I1
sS'subset'
p223
I12
sS'fatal class'
p224
I1
sS'non-respond'
p225
I2
sS'majority vot'
p226
I1
sS'lymphoblastic leukemia'
p227
I1
sS'interv'
p228
I1
sS'potential target antigen'
p229
I1
sS't cell'
p230
I1
sS'marker'
p231
I1
sS'growth'
p232
I1
sS'sampl'
p233
I1
sS'microarray experi'
p234
I1
sS'sight'
p235
I1
sS'year'
p236
I1
sS'malignant phenotyp'
p237
I1
sS'molecul'
p238
I1
sS'binary represent'
p239
I1
sS'network'
p240
I29
sS'cell-typ'
p241
I1
sS'best poss'
p242
I1
sS'categori'
p243
I1
sS'vector'
p244
I8
sS'relative depend'
p245
I1
sS'rm'
p246
I1
sS'gene panel'
p247
I3
sS'cox hazard'
p248
I1
sS'fl patient'
p249
I1
sS'machin'
p250
I1
sS'diseas'
p251
I2
sS'patient'
p252
I12
sS'prognost'
p253
I1
sS'agreement'
p254
I1
sS'target organ'
p255
I1
sS'disadvantage of neural network'
p256
I1
sS'hazard'
p257
I1
sS'tumor rejection antigen'
p258
I1
sS'panel'
p259
I4
sS'session'
p260
I2
sS'prognosi'
p261
I1
sS'tumor'
p262
I10
sS'informative gene mark'
p263
I1
sS'neighbor'
p264
I1
sS'metastatic diseas'
p265
I1
sS'predictor'
p266
I1
sS'softwar'
p267
I2
sS'major'
p268
I2
sS'error-free predict'
p269
I1
sS'non-specific similar'
p270
I1
sS'pairwise similar'
p271
I1
sS'som'
p272
I2
sS'surviv'
p273
I7
sS'assess'
p274
I2
sS'of cell-typ'
p275
I1
sS'survival outcom'
p276
I1
sS'optimum outcom'
p277
I1
sS'antibody-mediated immunotherapi'
p278
I1
sS'vote'
p279
I1
sS'correlation coeffici'
p280
I1
sS'informative subset'
p281
I1
sS'stage'
p282
I1
sS'rms error'
p283
I1
sS'blue-cell tumor'
p284
I1
sS'aml pati'
p285
I1
sS'survival classif'
p286
I1
sS'chemotherapi'
p287
I1
sS'neural net profil'
p288
I1
sS'diagnostic network'
p289
I1
sS'quantitative assess'
p290
I1
sS'fraction'
p291
I1
sS'immunotherapi'
p292
I1
sS'kaplan meier estim'
p293
I1
sS'tool'
p294
I1
sS'software program'
p295
I1
sS'dlbcl lymphoma'
p296
I1
sS'autoimmune diseas'
p297
I1
sS'round-robin fashion'
p298
I1
sS'year prognosi'
p299
I1
sS'tumor reject'
p300
I2
sS'gene expression panel'
p301
I1
sS'numerous recent cancer studi'
p302
I1
sS'diagnosis network'
p303
I1
sS'target'
p304
I2
sS'possibl'
p305
I1
sS'preparation for differenti'
p306
I1
sS'pc'
p307
I1
sS'for limiting tumor growth'
p308
I1
sS'proportional hazard'
p309
I1
sS'recent cancer studi'
p310
I1
sS'network strategi'
p311
I1
sS'tyrosine kinase receptor'
p312
I1
sS'meier estim'
p313
I1
sS'similar'
p314
I4
sS'gene mark'
p315
I1
sS'classif'
p316
I25
sS'fashion'
p317
I1
sS'near-perfect diagnosi'
p318
I1
sS'gene subset'
p319
I4
sS'cutoff criteria'
p320
I1
sS'ann'
p321
I4
sS'diagnosi'
p322
I3
sS'gene predictor'
p323
I1
sS'repres'
p324
I1
sS'round blue-cell tumor'
p325
I1
sS'germinal center b'
p326
I1
sS'b cell-like tumor'
p327
I3
sS'near-perfect classif'
p328
I1
sS'absolute best'
p329
I1
sS'diffuse large b-cell lymphoma'
p330
I1
sS'estim'
p331
I1
sS'normal train'
p332
I1
sS'accuraci'
p333
I12
sS'myeloid leukemia'
p334
I1
sS'efficacious approaches for limiting tumor'
p335
I1
sS'sigmoid transf'
p336
I1
sS'neural network softwar'
p337
I1
sS'kaplan'
p338
I2
sS'donor'
p339
I14
sS'phenotyp'
p340
I1
sS'node'
p341
I1
sS'round-robin'
p342
I1
sS'subsequent network'
p343
I1
sS'ly1'
p344
I1
sS'gene pool'
p345
I1
sS'maximum contribut'
p346
I1
sS'reserve pati'
p347
I1
sS'dlbcl patient'
p348
I3
sS'diagnosis unimpair'
p349
I1
sS'class'
p350
I3
sS'pool'
p351
I2
sS'matrix'
p352
I2
sS'svm'
p353
I1
sS'microarray studi'
p354
I1
sS'for individual pati'
p355
I1
sS'training interv'
p356
I1
sS'individual basi'
p357
I1
sS'rule'
p358
I1
sS'majority pol'
p359
I1
sS'over-train'
p360
I1
sS'profil'
p361
I4
sS'intuit'
p362
I1
stp363
Rp364
(dp365
S'_N'
p366
I694
sS'_max_cache'
p367
NsS'_item_cache'
p368
NsS'_Nr_cache'
p369
Nsbtp370
.